These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17689929)

  • 21. [Drinking motivates, depending on the use of tobacco and cannabis among adolescents].
    Dzielska A
    Przegl Lek; 2014; 71(11):592-6. PubMed ID: 25799851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing sexuality attitudes and behaviors and correlates of alcohol and drugs.
    Donnelly J; Goldfarb ES; Ferraro H; Eadie C; Duncan DF
    Psychol Rep; 2001 Jun; 88(3 Pt 1):849-53. PubMed ID: 11508032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trends in the consumption of tobacco, alcohol and cannabis among adolescents of Barcelona, Spain, between 1987 and 2004].
    Nebot M; Giménez E; Ariza C; Tomás Z
    Med Clin (Barc); 2006 Feb; 126(4):159. PubMed ID: 16472505
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study.
    McCreadie RG;
    Br J Psychiatry; 2002 Oct; 181():321-5. PubMed ID: 12356659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Legal substance use and the development of a DSM-IV cannabis use disorder during adolescence: the TRAILS study.
    Prince van Leeuwen A; Creemers HE; Verhulst FC; Vollebergh WA; Ormel J; van Oort F; Huizink AC
    Addiction; 2014 Feb; 109(2):303-11. PubMed ID: 24033662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobacco smoking in Egyptian schizophrenia patients with and without obsessive-compulsive symptoms.
    Fawzi MH; Fawzi MM; Khedr HH; Fawzi MM
    Schizophr Res; 2007 Sep; 95(1-3):236-46. PubMed ID: 17662578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking in first-episode patients with schizophrenia.
    McEvoy JP; Brown S
    Am J Psychiatry; 1999 Jul; 156(7):1120-1. PubMed ID: 10401475
    [No Abstract]   [Full Text] [Related]  

  • 28. Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology.
    Bersani G; Orlandi V; Gherardelli S; Pancheri P
    Psychopathology; 2002; 35(5):289-95. PubMed ID: 12457020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cannabis and schizophrenia. From euphoria to psychosis].
    Berger N
    Rev Med Liege; 2004 Feb; 59(2):98-103. PubMed ID: 15112899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users.
    Bonn-Miller MO; Vujanovic AA; Feldner MT; Bernstein A; Zvolensky MJ
    J Trauma Stress; 2007 Aug; 20(4):577-86. PubMed ID: 17721963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Related, induced and associated psychiatric disorders to cannabis].
    Laqueille X
    Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the gateway hypothesis, the common liability model and/or, the route of administration model predict initiation of cannabis use during adolescence? A survival analysis--the TRAILS study.
    van Leeuwen AP; Verhulst FC; Reijneveld SA; Vollebergh WA; Ormel J; Huizink AC
    J Adolesc Health; 2011 Jan; 48(1):73-8. PubMed ID: 21185527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence.
    Hiemstra M; Nelemans SA; Branje S; van Eijk KR; Hottenga JJ; Vinkers CH; van Lier P; Meeus W; Boks MP
    Drug Alcohol Depend; 2018 Sep; 190():143-150. PubMed ID: 30031300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of maternal smoking and alcohol consumption with young adults' cannabis use: a prospective study.
    Hayatbakhsh MR; Alati R; Hutchinson DM; Jamrozik K; Najman JM; Mamun AA; O'callaghan M; Bor W
    Am J Epidemiol; 2007 Sep; 166(5):592-8. PubMed ID: 17566065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
    Flanders SE
    Aust N Z J Psychiatry; 2007 Nov; 41(11):934-6. PubMed ID: 17924247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relevance of age at first alcohol and nicotine use for initiation of cannabis use and progression to cannabis use disorders.
    Behrendt S; Beesdo-Baum K; Höfler M; Perkonigg A; Bühringer G; Lieb R; Wittchen HU
    Drug Alcohol Depend; 2012 Jun; 123(1-3):48-56. PubMed ID: 22071122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.